Defence Therapeutics's total assets for Q3 2024 were C$2.36M, an increase of 486.46% from the previous quarter. DTCFF total liabilities were C$2.58M for the fiscal quarter, a -33.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.